71 related articles for article (PubMed ID: 12372891)
1. Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytes.
Torabi-Pour N; Nouri AM; Saffie R; Morrow WJ; Oliver RT
Urol Int; 2002; 69(3):219-26. PubMed ID: 12372891
[TBL] [Abstract][Full Text] [Related]
2. Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
Torabi-Pour N; Nouri AM; Perrett D; Oliver RT
Biomed Chromatogr; 2001 Feb; 15(1):18-24. PubMed ID: 11180296
[TBL] [Abstract][Full Text] [Related]
3. Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptides.
Torabi-Pour N; Nouri AM; Saffie R; Oliver RT
Urol Int; 2002; 68(1):38-43. PubMed ID: 11803266
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patients.
Torabi-Pour N; Nouri AM; Saffie R; Oliver RT
Urol Int; 2002; 68(3):183-8. PubMed ID: 11919465
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
6. Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation.
Gillott DJ; Nouri AM; Compton SJ; Oliver RT
J Immunol Methods; 1993 Oct; 165(2):231-9. PubMed ID: 8228273
[TBL] [Abstract][Full Text] [Related]
7. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.
Storkus WJ; Zeh HJ; Salter RD; Lotze MT
J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):94-103. PubMed ID: 7506576
[TBL] [Abstract][Full Text] [Related]
8. The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation.
Nouri AM; Hussain RF; Oliver RT
Cancer Gene Ther; 1994 Jun; 1(2):119-23. PubMed ID: 7621243
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantification of antigens associated with HLA class I molecules on a bladder tumour cell line. Implications for vaccine design.
Torabi-Pour N; Morrow WJ; Saffie R; Gowda PG; Perrett D; Oliver TR
Urol Int; 2003; 70(3):154-60. PubMed ID: 12660449
[TBL] [Abstract][Full Text] [Related]
10. Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.
Millo E; Pietra G; Armirotti A; Vacca P; Mingari MC; Moretta L; Damonte G
J Immunol Methods; 2007 Apr; 322(1-2):128-36. PubMed ID: 17331531
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
Sumitran-Karuppan S; Möller E
Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
[TBL] [Abstract][Full Text] [Related]
12. A new strategy for tumor antigen discovery based on in vitro priming of naive T cells with dendritic cells.
Kao H; Amoscato AA; Ciborowski P; Finn OJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):773s-780s. PubMed ID: 11300472
[TBL] [Abstract][Full Text] [Related]
13. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
[TBL] [Abstract][Full Text] [Related]
14. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
Vigna JL; Smith KD; Lutz CT
J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.
Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
J Immunother; 2007; 30(5):499-505. PubMed ID: 17589290
[TBL] [Abstract][Full Text] [Related]
16. Responses of peptide-specific T cells to stimulation with polystyrene beads carrying HLA class I molecules loaded with single peptides.
Chersi A; Galati R; Accapezzato D; Francavilla V; Barnaba V; Butler RH; Tanigaki N
J Immunol Methods; 2004 Aug; 291(1-2):79-91. PubMed ID: 15345307
[TBL] [Abstract][Full Text] [Related]
17. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
18. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
20. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
